2020
Pharmacology
Amin H, Schindler J. Pharmacology. 2020, 235-241. DOI: 10.1007/978-3-030-52552-1_19.ChaptersConcomitant medical comorbiditiesManagement of patientsStroke therapeuticsMedical comorbiditiesAcute strokeSecondary preventionCerebrovascular diseaseVascular neurologistsClinical indicationsPharmacological basisNeurologistsTherapeuticsHypertensionComorbiditiesHyperlipidemiaThrombosisOutpatientsPatientsInternistsCardiologistsStrokeDiseaseSeverityPreventionPharmacology
2019
Management of Hyperlipidemia After Stroke
Brooks DC, Schindler JL. Management of Hyperlipidemia After Stroke. Current Treatment Options In Cardiovascular Medicine 2019, 21: 93. PMID: 31840196, DOI: 10.1007/s11936-019-0774-8.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsManagement of hyperlipidemiaKey therapeutic targetCardiovascular diseaseTherapeutic targetAggressive LDL-C reductionStroke risk reductionLDL-C reductionAtherosclerotic vascular diseaseAvailable treatment optionsGeneral cardiovascular diseaseRecent FindingsStatinsIschemic strokePCSK9 inhibitorsHemorrhagic strokeRisk modificationTreatment optionsVascular diseaseRecent trialsNovel agentsNew agentsMost subtypesHyperlipidemiaStrokePatientsDisease
2016
Pharmacology
Amin H, Schindler J. Pharmacology. 2016, 177-183. DOI: 10.1007/978-3-319-39605-7_19.ChaptersConcomitant medical comorbiditiesManagement of patientsStroke therapeuticsMedical comorbiditiesAcute strokeSecondary preventionCerebrovascular diseaseVascular neurologistsClinical indicationsPharmacological basisNeurologistsTherapeuticsHypertensionComorbiditiesHyperlipidemiaThrombosisOutpatientsPatientsInternistsCardiologistsStrokeDiseaseSeverityPreventionPharmacology